CLOS
ZSAN

Compagnie Lombard Odier SCmA’s Zosano Pharma Corporation ZSAN Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,714
Closed -$32K – 694
2020
Q4 		$32K Hold
1,714
– – ﹤0.01% 479
2020
Q3 		$97K Hold
1,714
– – ﹤0.01% 337
2020
Q2 		$51K Hold
1,714
– – ﹤0.01% 375
2020
Q1 		$34K Buy
+1,714
New +$57.5K ﹤0.01% 374

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ZSAN Position: Q1 2021 in Review

Compagnie Lombard Odier SCmA sold out of Zosano Pharma Corporation (ZSAN) in Q1 2021, closing a stake of 1,714 shares — an estimated $32K sold.

Compagnie Lombard Odier SCmA first reported a position in ZSAN in Q1 2020 and held it in 4 quarters. The position peaked at $97K in Q3 2020. 35 funds tracked by Wall St. Rank hold ZSAN as of Q1 2021.

  • Compagnie Lombard Odier SCmA reported no remaining Zosano Pharma Corporation position as of Q1 2021 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 1,714 Zosano Pharma Corporation shares in Q1 2021, an estimated $32K.
  • Compagnie Lombard Odier SCmA first reported a position in Zosano Pharma Corporation in Q1 2020 and held it in 4 quarters.
  • Compagnie Lombard Odier SCmA's Zosano Pharma Corporation position peaked at $97K in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2021.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2021, filed 23 Apr 2021.